Idea Transcript
HOME
CHI SIAMO
English
RIVISTE
LIBRI
SERVIZI
CONTATTACI
SOTTOMISSIONE ONLINE
FORMAZIONE A DISTANZA
Italiano
Login Non ancora registrato? Registrati
cerca Ricerca avanzata
Home > Riviste > Minerva Pediatrica > Fascicoli precedenti > Minerva Pediatrica 2017 August;69(4) > Minerva Pediatrica 2017 August;69(4):274-80 I TUOI DATI
FASCICOLI E ARTICOLI
Modifica i dati di registrazione
LA RIVISTA
PER GLI AUTORI
ABBONAMENTI
MINERVA PEDIATRICA
Modifica la password I TUOI ORDINI
Rivista di Pediatria, Neonatologia, Medicina dell’Adolescenza e Neuropsichiatria Infantile
Ordine da completare Ordini completati CESTINO ACQUISTI
Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus Impact Factor 0,764
N. prodotti: 0 Totale ordine: € 0,00 Dettagli e completamento ordine COME ORDINARE
eTOC
ORIGINAL ARTICLE
Riviste Libri
Minerva Pediatrica 2017 August;69(4):274-80
I TUOI ABBONAMENTI Attiva Visualizza Contatta ufficio abbonamenti
DOI: 10.23736/S0026-4946.16.04244-4 Copyright © 2015 EDIZIONI MINERVA MEDICA lingua: Inglese
Visualizza
Predictive risk factors for relapse after cessation of inhaled corticosteroids in well-controlled childhood asthma
ACCESSIBILITÀ
Hacer AKTURK 1, Elif, KARAKOC-AYDINER 2
Carattere normale
Isil BARLAN 2
Carattere più grande
1 Department of Pediatrics, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; 2 Department of Pediatric Allergy and
I TUOI ARTICOLI
Solo testo Alta leggibilità
) , Ahmet OZEN , Safa BARIS , Tunc AKKOC , Nerin Nadir BAHCECILER , 2
2
2
3
ARTICLE TOOLS Publication history
Immunology, Marmara Medical Faculty, Istanbul, Turkey; 3 Department of Pediatric Allergy and Immunology, Near East University Medical School, Nicosia, Cyprus
Estratti Per citare questo articolo
PDF BACKGROUND: There is limited data for predicting the risk of exacerbations following the cessation of inhaled corticosteroids (ICS) in well controlled childhood asthma. In current study, clinical, functional and inflammatory parameters at the time of ICS withdrawal were investigated in that respect. METHODS: Forty children asymptomatic for at least 3 months on low dose ICS’s were enrolled and ICS were discontinued in summer. At enrolment symptom/medication diary, pulmonary function parameters, methacholine provocation testing, peripheral blood eosinophilia, serum total and allergen-specific IgE levels and skin prick testing were performed. In a subgroup of patients, phytohemaglutinin induced secretion of IL-5, IL-13, IFN- and IL-10 from blood mononuclear cells were measured. Patients were assessed with symptom/medication diary and pulmonary function test every 2 months for 6 months. RESULTS: Eighteen of 37 patients experienced recurrence of acute asthma symptoms. In patients with acute attack (group I), changes in rhinitis symptom scores at 2nd month vs. baseline were statistically higher. In addition, group I had significantly higher rhinitis symptom scores compared to group II at fourth-month visit. Patients with acute exacerbation revealed a significant decrease in FEV1% at 2nd month compared to baseline. Moreover, group I showed significantly lower FEF 25-75% compared to group II at 2nd month. Baseline bronchial hyper-responsiveness with methacholine was found to be an independent risk factor for asthma exacerbation. CONCLUSIONS: The findings of this study identified baseline bronchial hyperreactivity, higher rhinitis symptom scores and gradual decrease in pulmonary function parameters during follow-up as risk factors for subsequent exacerbation of asthma. KEY WORDS: Asthma - Bronchial hyperreactivity - Rhinitis - Cytokine inizio pagina
Utilizziamo i cookie per migliorare la tua esperienza di navigazione sul nostro sito. Continuando la navigazione acconsenti all'utilizzo dei cookie. Copyright © 2017 Edizioni Minerva Medica Dati societari Privacy policy Termini e condizioni Per maggiori informazioni cliccare qui.